Real‐World Data on the p. Gly17Val RHOA Mutation in Diagnosing T Follicular Helper Cell Lymphomas
Open Access
- 10 May 2025
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 14 (9) , e70955
Abstract
Background: T follicular helper (Tfh) cell lymphomas, including their most prevalent form, angioimmunoblastic T‐cell lymphoma, frequently present with clinical symptoms, such as fever and rash, accompanied by substantial immune cell infiltration within the tumor microenvironment. These features often obscure the distinction between Tfh lymphoma and other autoimmune or inflammatory conditions. Notably, the p.Gly17Val RHOA (G17V) mutation is commonly associated with Tfh lymphomas, including angioimmunoblastic T‐cell lymphoma, suggesting that testing for the G17V mutation may serve as a valuable diagnostic tool. However, it remains unclear which patients would benefit the most from G17V mutation testing. Methods: In this study, we retrospectively reviewed the medical records of 224 patients tested for the G17V mutation as part of routine clinical practice. Results: We detected G17V in 17 patients. Among Tfh lymphoma cases, the sensitivity and specificity of the G17V test were 0.533 and 0.955, respectively. We further explored the association between G17V positivity and the clinical features of patients undergoing testing for the first time ( n = 186). The G17V mutation was more frequent in patients presenting with lymphadenopathy in combination with fever or skin rash and elevated soluble interleukin‐2 receptor levels ( p = 0.002). The median time from G17V test submission to results was 11.6 d shorter than that for pathological diagnosis ( p = 0.0009). Conclusions: Given the noninvasive nature of the G17V test, its rapid administration to appropriate patients is expected to enable faster and more efficient diagnosis of Tfh lymphomas compared with conventional methods.Keywords
Funding Information
- Takeda Science Foundation
- Kobayashi Foundation for Cancer Research
- Uehara Memorial Foundation
- Japan Agency for Medical Research and Development (JP23ck0106797)
- Japan Agency for Medical Research and Development (JP24ck0106908)
- Japan Agency for Medical Research and Development (Moonshot Research and Development Program)
This publication has 22 references indexed in Scilit:
- A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphomaNature Genetics, 2014
- Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomasNature Genetics, 2014
- Somatic RHOA mutation in angioimmunoblastic T cell lymphomaNature Genetics, 2014
- Atypical angioimmunoblastic T-cell lymphomas masquerading as systemic polyclonal B-immunoblastic proliferationVirchows Archiv, 2012
- Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in JapanBlood, 2012
- Advances in the understanding and management of angioimmunoblastic T‐cell lymphomaBritish Journal of Haematology, 2010
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008
- Angioimmunoblastic T‐cell lymphomaBritish Journal of Haematology, 2003
- Detection of Single-Nucleotide Polymorphisms with the WAVE™ DNA Fragment Analysis SystemGenetic Testing, 1997
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974